arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Cybin Inc.

HELP Health Care Biotechnology: Pharmaceutical Preparations
$7.82
Today
as of Jul 22, 16:49 ET
Last 30 days +81.86% Jun 12 → Jul 22
$3.94 $5.06 $6.18 $7.29 $8.41 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$4.45
High
$4.50
Low
$4.07
Volume
$808,406
Avg Vol
$775,709
Mkt Cap
$441M
P/E (TTM)
—
Beta
—
52w High
$9.83
52w Low
$4.07
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 3 items

Jul 17 · 09:13 Simply Wall St.
Cybin (HELP) Is Up 6.2% After Advancing HLP003 To Phase 3 And Raising US$50 Million
Jul 15 · 09:22 Insider Monkey
Is Cybin D/B/A Helus Pharma (HELP) Stock a Psychedelic Medicine Opportunity Ahead of HLP003 Trial Results?
Jun 26 · 22:09 Simply Wall St.
Cybin (HELP) Is Up 28.9% After Phase 3 HLP003 Progress And $50M Equity Raise - Has The Bull Case Changed?

Overview

52-week range
$4.07
$9.83
65% of range
Avg surprise (last 3)
-71.9%
Avg reaction (last 1)
+2.9%
100% positive
Latest IV / EM
95%
EM ±21.6% · $8 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.10$-0.84$-0.58$-0.31$-0.05 Actual $-0.05Est $-0.05Actual $-1.02Est $-0.51Actual $-1.10Est $-0.51 Mar/2023Mar/2025Jun/2025

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 13, 2025Jun/2025 $-1.10 $-0.51 -115.7% — — earnings
Mon Jun 30, 2025Mar/2025 $-1.02 $-0.51 -100.0% — +2.9% earnings
Tue Jun 27, 2023Mar/2023 $-0.05 $-0.05 0.0% — — earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 12, 2026Jun/2026OTHER -$0.80-$1.10 +27.3%

Implied volatility — last 90 days

26%152%279%406%532% Jun 07 — IV 139% · EM ±19.3%Jun 08 — IV 316% · EM ±41.7%Jun 09 — IV 506% · EM ±63.5%Jun 10 — IV 372% · EM ±43.9%Jun 11 — IV 492% · EM ±54.3%Jun 12 — IV 199% · EM ±20.3%Jun 15 — IV 488% · EM ±35.3%Jun 16 — IV 533% · EM ±31.5%Jun 17 — IV 497% · EM ±20.7%Jun 19 — IV 124% · EM ±27.3%Jun 22 — IV 128% · EM ±26.8%Jun 23 — IV 86% · EM ±17.5%Jun 24 — IV 69% · EM ±13.8%Jun 25 — IV 147% · EM ±28.9%Jun 26 — IV 221% · EM ±42.2%Jun 29 — IV 238% · EM ±42.2%Jun 30 — IV 273% · EM ±46.9%Jul 01 — IV 272% · EM ±45.5%Jul 02 — IV 126% · EM ±20.4%Jul 03 — IV 131% · EM ±20.4%Jul 06 — IV 276% · EM ±38.3%Jul 07 — IV 210% · EM ±27.7%Jul 08 — IV 281% · EM ±35.2%Jul 09 — IV 262% · EM ±30.9%Jul 10 — IV 26% · EM ±2.9%Jul 20 — IV 80% · EM ±19.0%Jul 21 — IV 105% · EM ±24.5%Jul 22 — IV 95% · EM ±21.6%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in